Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
38
JKHY Quote, Financials, Valuation and Earnings
Last price:
$176.75
Seasonality move
:
9.74%
Day range:
$174.96 - $178.40
52-week range:
$157.00 - $189.63
Dividend yield:
1.25%
P/E ratio:
32.35x
P/S ratio:
5.75x
P/B ratio:
6.70x
Volume:
862.5K
Avg. volume:
700.2K
1-year change:
8.5%
Market cap:
$12.9B
Revenue:
$2.2B
EPS (TTM):
$5.46
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.8B | $1.9B | $2.1B | $2.2B | |
| Revenue Growth (YoY) | 9.3% | 3.6% | 10.5% | 6.94% | 6.63% | |
| Cost of Revenues | $1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Gross Profit | $688.6M | $694.8M | $814.3M | $858.6M | $916.1M | |
| Gross Profit Margin | 40.58% | 39.52% | 41.91% | 41.33% | 41.35% | |
| R&D Expenses | $110M | $109M | $121.4M | $142.7M | $148.3M | |
| Selling, General & Admin | $198M | $187.1M | $218.3M | $235.3M | $278.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $308M | $296.1M | $339.7M | $378M | $426.7M | |
| Operating Income | $380.6M | $398.7M | $474.6M | $480.7M | $489.4M | |
| Net Interest Expenses | -- | $994K | $2.4M | $6.1M | -- | |
| EBT. Incl. Unusual Items | $381.1M | $397.7M | $472.3M | $474.6M | $498M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $84.4M | $86.3M | $109.4M | $107.9M | $116.2M | |
| Net Income to Company | $296.7M | $311.5M | $362.9M | $366.6M | $381.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $296.7M | $311.5M | $362.9M | $366.6M | $381.8M | |
| Basic EPS (Cont. Ops) | $3.86 | $4.12 | $4.95 | $5.03 | $5.24 | |
| Diluted EPS (Cont. Ops) | $3.86 | $4.12 | $4.94 | $5.02 | $5.23 | |
| Weighted Average Basic Share | $76.8M | $75.5M | $73.3M | $72.9M | $72.9M | |
| Weighted Average Diluted Share | $76.9M | $75.7M | $73.5M | $73.1M | $73M | |
| EBITDA | $553.6M | $574.6M | $652.3M | $680.4M | $714.3M | |
| EBIT | $381.8M | $398.9M | $474.7M | $489.6M | $514.4M | |
| Revenue (Reported) | $1.7B | $1.8B | $1.9B | $2.1B | $2.2B | |
| Operating Income (Reported) | $380.6M | $398.7M | $474.6M | $480.7M | $489.4M | |
| Operating Income (Adjusted) | $381.8M | $398.9M | $474.7M | $489.6M | $514.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $451.8M | $488.1M | $529.2M | $571.4M | $601M | |
| Revenue Growth (YoY) | 3.15% | 8.03% | 8.43% | 7.97% | 5.18% | |
| Cost of Revenues | $262.9M | $276.6M | $298.3M | $323M | $343.4M | |
| Gross Profit | $188.9M | $211.4M | $230.9M | $248.4M | $257.6M | |
| Gross Profit Margin | 41.8% | 43.32% | 43.64% | 43.47% | 42.86% | |
| R&D Expenses | $26.1M | $26.8M | $33M | $36.9M | $39.7M | |
| Selling, General & Admin | $45.2M | $51.1M | $57.2M | $78.8M | $66.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $71.3M | $77.8M | $90.2M | $115.7M | $106.3M | |
| Operating Income | $117.6M | $133.6M | $140.7M | $132.7M | $151.3M | |
| Net Interest Expenses | $49K | $241K | $1.4M | -- | -- | |
| EBT. Incl. Unusual Items | $117.5M | $133.4M | $139.3M | $133.2M | $156.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26.3M | $31.2M | $32.8M | $31.6M | $37.6M | |
| Net Income to Company | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Basic EPS (Cont. Ops) | $1.19 | $1.38 | $1.46 | $1.40 | $1.63 | |
| Diluted EPS (Cont. Ops) | $1.19 | $1.38 | $1.46 | $1.39 | $1.63 | |
| Weighted Average Basic Share | $76.5M | $74M | $72.9M | $72.9M | $72.9M | |
| Weighted Average Diluted Share | $76.7M | $74.1M | $73.1M | $73M | $73.1M | |
| EBITDA | $161.4M | $177.8M | $186.5M | $186.7M | $210.1M | |
| EBIT | $117.7M | $133.6M | $140.9M | $137.4M | $159.6M | |
| Revenue (Reported) | $451.8M | $488.1M | $529.2M | $571.4M | $601M | |
| Operating Income (Reported) | $117.6M | $133.6M | $140.7M | $132.7M | $151.3M | |
| Operating Income (Adjusted) | $117.7M | $133.6M | $140.9M | $137.4M | $159.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.8B | $2B | $2.1B | $2.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.1B | $1.2B | $1.2B | $1.3B | |
| Gross Profit | $685.3M | $717.4M | $833.8M | $876.1M | $925.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $111.5M | $109.7M | $127.6M | $146.6M | $151.1M | |
| Selling, General & Admin | $193.8M | $192.9M | $224.4M | $256.8M | $266.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $305.2M | $302.6M | $352M | $403.4M | $417.3M | |
| Operating Income | $380M | $414.7M | $481.7M | $472.7M | $508M | |
| Net Interest Expenses | -- | $1.2M | $3.5M | $4.1M | -- | |
| EBT. Incl. Unusual Items | $380.1M | $413.5M | $478.2M | $468.5M | $521.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $81.6M | $91.2M | $110.9M | $106.7M | $122.2M | |
| Net Income to Company | $298.5M | $322.4M | $367.4M | $361.8M | $399.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $298.5M | $322.4M | $367.4M | $361.8M | $399.3M | |
| Basic EPS (Cont. Ops) | $3.89 | $4.31 | $5.02 | $4.97 | $5.48 | |
| Diluted EPS (Cont. Ops) | $3.89 | $4.31 | $5.02 | $4.95 | $5.46 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $554.2M | $591M | $661M | $680.6M | $737.7M | |
| EBIT | $380.7M | $414.8M | $481.9M | $486.2M | $536.6M | |
| Revenue (Reported) | $1.7B | $1.8B | $2B | $2.1B | $2.2B | |
| Operating Income (Reported) | $380M | $414.7M | $481.7M | $472.7M | $508M | |
| Operating Income (Adjusted) | $380.7M | $414.8M | $481.9M | $486.2M | $536.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $451.8M | $488.1M | $529.2M | $571.4M | $601M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $262.9M | $276.6M | $298.3M | $323M | $343.4M | |
| Gross Profit | $188.9M | $211.4M | $230.9M | $248.4M | $257.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $26.1M | $26.8M | $33M | $36.9M | $39.7M | |
| Selling, General & Admin | $45.2M | $51.1M | $57.2M | $78.8M | $66.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $71.3M | $77.8M | $90.2M | $115.7M | $106.3M | |
| Operating Income | $117.6M | $133.6M | $140.7M | $132.7M | $151.3M | |
| Net Interest Expenses | $49K | $241K | $1.4M | -- | -- | |
| EBT. Incl. Unusual Items | $117.5M | $133.4M | $139.3M | $133.2M | $156.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26.3M | $31.2M | $32.8M | $31.6M | $37.6M | |
| Net Income to Company | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Basic EPS (Cont. Ops) | $1.19 | $1.38 | $1.46 | $1.40 | $1.63 | |
| Diluted EPS (Cont. Ops) | $1.19 | $1.38 | $1.46 | $1.39 | $1.63 | |
| Weighted Average Basic Share | $76.5M | $74M | $72.9M | $72.9M | $72.9M | |
| Weighted Average Diluted Share | $76.7M | $74.1M | $73.1M | $73M | $73.1M | |
| EBITDA | $161.4M | $177.8M | $186.5M | $186.7M | $210.1M | |
| EBIT | $117.7M | $133.6M | $140.9M | $137.4M | $159.6M | |
| Revenue (Reported) | $451.8M | $488.1M | $529.2M | $571.4M | $601M | |
| Operating Income (Reported) | $117.6M | $133.6M | $140.7M | $132.7M | $151.3M | |
| Operating Income (Adjusted) | $117.7M | $133.6M | $140.9M | $137.4M | $159.6M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $213.3M | $51M | $48.8M | $12.2M | $38.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $300.9M | $313.8M | $355.7M | $369.2M | $340.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $95.5M | $109.7M | $125.5M | $169.2M | $168.8M | |
| Total Current Assets | $669.1M | $543.7M | $613.5M | $628M | $632M | |
| Property Plant And Equipment | $273.4M | $252.5M | $211.7M | $205.7M | $215.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $686.3M | $687.5M | $687.5M | $804.8M | $804.8M | |
| Other Intangibles | $465.5M | $476.1M | $505.6M | $651.2M | $671.7M | |
| Other Long-Term Assets | $220.6M | $249.2M | $293.5M | $322.7M | $417.6M | |
| Total Assets | $2.4B | $2.3B | $2.5B | $2.8B | $2.9B | |
| Accounts Payable | $9.9M | $18.5M | $21M | $19.2M | $25.3M | |
| Accrued Expenses | $166.7M | $182.5M | $192M | $172.6M | $200.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $90M | |
| Current Portion Of Capital Lease Obligations | $115K | $110K | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $494.8M | $520.9M | $543.8M | $523.8M | $633.8M | |
| Long-Term Debt | -- | $100M | $115M | $275M | $60M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $878.8M | $1B | $1.1B | $1.2B | $1.1B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.5B | $1.3B | $1.4B | $1.6B | $1.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $1.3B | $1.4B | $1.6B | $1.8B | |
| Total Liabilities and Equity | $2.4B | $2.3B | $2.5B | $2.8B | $2.9B | |
| Cash and Short Terms | $213.3M | $51M | $48.8M | $12.2M | $38.3M | |
| Total Debt | -- | $100M | $115.1M | $275M | $150M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $195.3M | $44.3M | $32M | $31.5M | $43.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $223M | $253.2M | $255.6M | $296.9M | $313.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $103.1M | $111.3M | $134.5M | $163.7M | $190.5M | |
| Total Current Assets | $574.5M | $491M | $485.1M | $563.5M | $634.5M | |
| Property Plant And Equipment | $263.7M | $241.2M | $208.3M | $202.8M | $212.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $686.3M | $687.5M | $804.2M | $804.8M | $804.8M | |
| Other Intangibles | $468.3M | $481.4M | $631.5M | $657.9M | $676.3M | |
| Other Long-Term Assets | $225.2M | $248.9M | $300.9M | $334.8M | $413.8M | |
| Total Assets | $2.3B | $2.3B | $2.6B | $2.7B | $2.9B | |
| Accounts Payable | $6.8M | $14M | $20.4M | $20.3M | $20.5M | |
| Accrued Expenses | $144.8M | $147.1M | $147.7M | $157.9M | $180.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $90M | |
| Current Portion Of Capital Lease Obligations | -- | $110K | $41K | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $407.4M | $430M | $470.3M | $470.6M | $570.7M | |
| Long-Term Debt | $169K | $65M | $245M | $245M | $50M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $791.3M | $885.2M | $1.1B | $1.1B | $1B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $1.4B | $1.5B | $1.7B | $1.9B | |
| Total Liabilities and Equity | $2.3B | $2.3B | $2.6B | $2.7B | $2.9B | |
| Cash and Short Terms | $195.3M | $44.3M | $32M | $31.5M | $43.2M | |
| Total Debt | $295K | $65M | $245M | $245M | $140M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $296.7M | $311.5M | $362.9M | $366.6M | $381.8M | |
| Depreciation & Amoritzation | $171.8M | $175.7M | $177.6M | $190.7M | $199.9M | |
| Stock-Based Compensation | $16.9M | $20.7M | $24.8M | $28.6M | $28.9M | |
| Change in Accounts Receivable | $10.5M | -$6.1M | -$41.5M | -$12.1M | $28.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $510.5M | $462.1M | $504.6M | $381.6M | $568M | |
| Capital Expenditures | $177.5M | $157.8M | $191.4M | $207M | $232.4M | |
| Cash Acquisitions | -$30.4M | -$2.3M | -- | -$229.6M | -- | |
| Cash From Investing | -$197.9M | -$162.3M | -$196.3M | -$409.7M | -$240.2M | |
| Dividends Paid (Ex Special Dividend) | -$127.4M | -$133.8M | -$139.1M | -$147.2M | -$155.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $55M | $200M | $332M | $810M | $475M | |
| Long-Term Debt Repaid | -$55M | -$100.1M | -$317.1M | -$650.1M | -$600M | |
| Repurchase of Common Stock | -$71.5M | -$431.5M | -$193.9M | -$25M | -$28.1M | |
| Other Financing Activities | -$3.7M | -$7.7M | -$4.2M | -$8.5M | -$5.4M | |
| Cash From Financing | -$192.9M | -$462.2M | -$310.5M | -$8.4M | -$301.8M | |
| Beginning Cash (CF) | $93.6M | $213.3M | $51M | $48.8M | $12.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $119.7M | -$162.4M | -$2.2M | -$36.5M | $26M | |
| Ending Cash (CF) | $213.3M | $51M | $48.8M | $12.2M | $38.3M | |
| Levered Free Cash Flow | $333M | $304.3M | $313.2M | $174.6M | $335.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Depreciation & Amoritzation | $43.7M | $44.2M | $45.6M | $49.2M | $50.5M | |
| Stock-Based Compensation | $4.6M | $6.1M | $7M | $7.1M | $6.7M | |
| Change in Accounts Receivable | $77.4M | $53.4M | $101.5M | $72.5M | $26.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $114.5M | $106.5M | $136.8M | $157.1M | $116.9M | |
| Capital Expenditures | $37.3M | $46.5M | $46.9M | $51.4M | $57.7M | |
| Cash Acquisitions | $6.1M | $14K | -$202.7M | $852K | -- | |
| Cash From Investing | -$31.2M | -$46.5M | -$249.6M | -$50.5M | -$58.7M | |
| Dividends Paid (Ex Special Dividend) | -$32.8M | -$34M | -$35.7M | -$37.9M | -$40.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $280M | $135M | $75M | |
| Long-Term Debt Repaid | -$28K | -$35M | -$150M | -$165M | -$85M | |
| Repurchase of Common Stock | -$65.9M | -- | -- | -$20M | -- | |
| Other Financing Activities | -$5.5M | -$953K | -$1.6M | -$2.9M | -$6.2M | |
| Cash From Financing | -$101.3M | -$66.8M | $95.9M | -$87.4M | -$53.2M | |
| Beginning Cash (CF) | $213.3M | $51M | $48.8M | $12.2M | $38.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$18M | -$6.7M | -$16.8M | $19.2M | $4.9M | |
| Ending Cash (CF) | $195.3M | $44.3M | $32M | $31.5M | $43.2M | |
| Levered Free Cash Flow | $77.2M | $60.1M | $90M | $105.8M | $59.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $298.5M | $322.4M | $367.4M | $361.8M | $399.3M | |
| Depreciation & Amoritzation | $173.5M | $176.2M | $179.1M | $194.4M | $201.2M | |
| Stock-Based Compensation | $18.7M | $22.2M | $25.7M | $28.8M | $28.4M | |
| Change in Accounts Receivable | $10.9M | -$30.1M | $6.6M | -$41.1M | -$17.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $502M | $454.2M | $534.9M | $401.9M | $527.8M | |
| Capital Expenditures | $170.8M | $167M | $191.8M | $211.5M | $238.8M | |
| Cash Acquisitions | $6M | -$8.4M | -$202.7M | -$26M | -$852K | |
| Cash From Investing | -$153.7M | -$177.5M | -$399.5M | -$210.6M | -$248.4M | |
| Dividends Paid (Ex Special Dividend) | -$129.5M | -$135M | -$140.7M | -$149.4M | -$158.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $200M | $612M | $665M | $415M | |
| Long-Term Debt Repaid | -$55.1M | -$135.1M | -$432.1M | -$665M | -$520M | |
| Repurchase of Common Stock | -$123.3M | -- | -$193.9M | -$45M | -$8.1M | |
| Other Financing Activities | -$7.2M | -$3.2M | -$4.8M | -$9.9M | -$8.6M | |
| Cash From Financing | -$249.6M | -$427.8M | -$147.7M | -$191.8M | -$267.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $98.6M | -$151.1M | -$12.3M | -$503K | $11.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $331.1M | $287.2M | $343.1M | $190.4M | $289M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $91.2M | $102.1M | $106.5M | $101.7M | $119.2M | |
| Depreciation & Amoritzation | $43.7M | $44.2M | $45.6M | $49.2M | $50.5M | |
| Stock-Based Compensation | $4.6M | $6.1M | $7M | $7.1M | $6.7M | |
| Change in Accounts Receivable | $77.4M | $53.4M | $101.5M | $72.5M | $26.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $114.5M | $106.5M | $136.8M | $157.1M | $116.9M | |
| Capital Expenditures | $37.3M | $46.5M | $46.9M | $51.4M | $57.7M | |
| Cash Acquisitions | $6.1M | $14K | -$202.7M | $852K | -- | |
| Cash From Investing | -$31.2M | -$46.5M | -$249.6M | -$50.5M | -$58.7M | |
| Dividends Paid (Ex Special Dividend) | -$32.8M | -$34M | -$35.7M | -$37.9M | -$40.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $280M | $135M | $75M | |
| Long-Term Debt Repaid | -$28K | -$35M | -$150M | -$165M | -$85M | |
| Repurchase of Common Stock | -$65.9M | -- | -- | -$20M | -- | |
| Other Financing Activities | -$5.5M | -$953K | -$1.6M | -$2.9M | -$6.2M | |
| Cash From Financing | -$101.3M | -$66.8M | $95.9M | -$87.4M | -$53.2M | |
| Beginning Cash (CF) | $213.3M | $51M | $48.8M | $12.2M | $38.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$18M | -$6.7M | -$16.8M | $19.2M | $4.9M | |
| Ending Cash (CF) | $195.3M | $44.3M | $32M | $31.5M | $43.2M | |
| Levered Free Cash Flow | $77.2M | $60.1M | $90M | $105.8M | $59.2M | |
Get JKHY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JKHY
Sector
P/E ratio
32.35x
11.99x
PEG ratio
3.14x
0.36x
P/B ratio
6.70x
1.05x
Price / LTM sales
5.75x
2.55x
Growth Metrics
JKHY
Sector
Revenue growth
5.18%
6.08%
Earnings growth
17.27%
6.45%
Revenue (5-year growth)
7.37%
5.85%
Earnings forecast
$1.60
$0.56
Profitability
JKHY
Sector
Profitability FY 2024
$916.1M
$179.9M
Return on invested capital
20.02%
5.27%
Return on assets
14.15%
0.98%
Return on equity
22.36%
9.43%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
6
Estimated Next Earnings Date
Feb
4
Balance Sheet
JKHY
Sector
Total cash
$43.2M
$615.3M
Short term investments
--
$408.4M
Total assets
$2.9B
$4.5B
Long term debt
$140M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
